Summit Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US86627T1088
USD
16.49
-5.07 (-23.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summarySummit Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-23.52%
0.03%
1W
-20.03%
-0.35%
1M
-31.18%
0.08%
YTD
-7.59%
1.02%
1Y
106.64%
13.02%
3Y
1621.29%
72.04%
5Y
386.43%
80.03%
10Y
386.43%
262.66%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.34%
0%
-8.34%
6 Months
-8.24%
0%
-8.24%
1 Year
106.64%
0%
106.64%
2 Years
842.29%
0%
842.29%
3 Years
1621.29%
0%
1621.29%
4 Years
131.93%
0%
131.93%
5 Years
386.43%
0%
386.43%

Summit Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary